PROCURENT OF XOFLUZA (BALOXAVIR MARBOXIL) 40MG AND 80MG TABLETS
$74,970,000
| Recipient | GENENTECH USA, INC UEI SA85BMHCTXK5 |
|---|---|
| Award ID | 75A50325F80036 |
| Award amount | $74,970,000 |
| Award type | DELIVERY ORDER |
| Awarding agency | Department of Health and Human Services — Office of Assistant Secretary for Preparedness and Response |
| NAICS | 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING |
| PSC | 6505 |
| Start date | Sep 26, 2025 |
| End date | Sep 29, 2027 |
| Place of performance | SOUTH SAN FRANCISCO, CA |
| Record updated | Mar 13, 2026 |
View the official award record
More awards won by GENENTECH USA, INC
65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Department of Veterans Affairs · $4,927,972,430 · Sep 15, 2023
OSELTAMIVIR PHOSPHATE (TAMIFLU) 30MG AND 75MG CAPSULES
Department of Health and Human Services · $45,107,051 · Jan 30, 2025
THE PURPOSE AND NEED FOR THIS PROPOSED REQUIREMENT IS TO PROVIDE THE DIVISION OF STRATEGIC NATIONAL STOCKPILE (DSNS), ASSISTANT SECRETARY OF PREPAREDNESS AND RESPONSE (ASPR), WITH A CONTRACTING VEHICLE FOR PRODUCT(S) NEEDED IN ORDER TO SUPPORT "
Department of Health and Human Services · $30,000,000 · Sep 14, 2022
XOFLUZA (BALOXAVIR MARBOXIL)
Department of Health and Human Services · $21,999,907 · Sep 30, 2024
NEW AWARD FOR RANIBIZUMAB (LUCENTIS) SYRINGES WITH GENENTECH USA, INC. PERIOD OF PERFORMANCE IS 12/23/23 TO 12/22/24 WITH FOUR ONE-YEAR OPTIONS.
Department of Veterans Affairs · $3,011,580 · Dec 23, 2023
Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.
Search open bids